Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. A pilot study

It is a clinical challenge to obtain a sufficient orthopaedic implant fixation in weak osteoporotic bone. When the primary implant fixation is poor, micromotions occur at the bone-implant interface, activating osteoclasts, which leads to implant loosening. Bisphosphonate can be used to prevent the o...

Full description

Bibliographic Details
Main Author: GVA Stadelmann
Format: Article
Language:English
Published: AO Research Institute Davos 2008-07-01
Series:European Cells & Materials
Subjects:
Online Access:http://www.ecmjournal.org/journal/papers/vol016/pdf/v016a02.pdf
id doaj-9b3ffebb10af4e71ab0df2f9dff2104a
record_format Article
spelling doaj-9b3ffebb10af4e71ab0df2f9dff2104a2020-11-24T21:04:48Zeng AO Research Institute DavosEuropean Cells & Materials1473-22622008-07-01161016Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. A pilot studyGVA StadelmannIt is a clinical challenge to obtain a sufficient orthopaedic implant fixation in weak osteoporotic bone. When the primary implant fixation is poor, micromotions occur at the bone-implant interface, activating osteoclasts, which leads to implant loosening. Bisphosphonate can be used to prevent the osteoclastic response, but when administered systemically its bioavailability is low and the time it takes for the drug to reach the periprosthetic bone may be a limiting factor. Recent data has shown that delivering bisphosphonate locally from the implant surface could be an interesting solution. Local bisphosphonate delivery increased periprosthetic bone density, which leads to a stronger implant fixation, as demonstrated in rats by the increased implant pullout force. The aim of the present study was to verify the positive effect on periprosthetic bone remodelling of local bisphosphonate delivery in an osteoporotic sheep model. Four implants coated with zoledronate and two control implants were inserted in the femoral condyle of ovariectomized sheep for 4 weeks. The bone at the implant surface was 50% higher in the zoledronate-group compared to control group. This effect was significant up to a distance of 400µm from the implant surface. The presented results are similar to what was observed in the osteoporotic rat model, which suggest that the concept of releasing zoledronate locally from the implant to increase the implant fixation is not species specific. The results of this trial study support the claim that local zoledronate could increase the fixation of an implant in weak bone. http://www.ecmjournal.org/journal/papers/vol016/pdf/v016a02.pdforthopaedic implantdrug delivery in vivosheepbisphosphonate coating
collection DOAJ
language English
format Article
sources DOAJ
author GVA Stadelmann
spellingShingle GVA Stadelmann
Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. A pilot study
European Cells & Materials
orthopaedic implant
drug delivery in vivo
sheep
bisphosphonate coating
author_facet GVA Stadelmann
author_sort GVA Stadelmann
title Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. A pilot study
title_short Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. A pilot study
title_full Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. A pilot study
title_fullStr Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. A pilot study
title_full_unstemmed Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. A pilot study
title_sort implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. a pilot study
publisher AO Research Institute Davos
series European Cells & Materials
issn 1473-2262
publishDate 2008-07-01
description It is a clinical challenge to obtain a sufficient orthopaedic implant fixation in weak osteoporotic bone. When the primary implant fixation is poor, micromotions occur at the bone-implant interface, activating osteoclasts, which leads to implant loosening. Bisphosphonate can be used to prevent the osteoclastic response, but when administered systemically its bioavailability is low and the time it takes for the drug to reach the periprosthetic bone may be a limiting factor. Recent data has shown that delivering bisphosphonate locally from the implant surface could be an interesting solution. Local bisphosphonate delivery increased periprosthetic bone density, which leads to a stronger implant fixation, as demonstrated in rats by the increased implant pullout force. The aim of the present study was to verify the positive effect on periprosthetic bone remodelling of local bisphosphonate delivery in an osteoporotic sheep model. Four implants coated with zoledronate and two control implants were inserted in the femoral condyle of ovariectomized sheep for 4 weeks. The bone at the implant surface was 50% higher in the zoledronate-group compared to control group. This effect was significant up to a distance of 400µm from the implant surface. The presented results are similar to what was observed in the osteoporotic rat model, which suggest that the concept of releasing zoledronate locally from the implant to increase the implant fixation is not species specific. The results of this trial study support the claim that local zoledronate could increase the fixation of an implant in weak bone.
topic orthopaedic implant
drug delivery in vivo
sheep
bisphosphonate coating
url http://www.ecmjournal.org/journal/papers/vol016/pdf/v016a02.pdf
work_keys_str_mv AT gvastadelmann implantsdeliveringbisphosphonatelocallyincreaseperiprostheticbonedensityinanosteoporoticsheepmodelapilotstudy
_version_ 1716769724874883072